Cardio DiagnosticsCDIO
CDIO
About: Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
Employees: 9
0
Funds holding %
of 7,139 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
530% more capital invested
Capital invested by funds: $374K [Q3] → $2.35M (+$1.98M) [Q4]
53% more funds holding
Funds holding: 15 [Q3] → 23 (+8) [Q4]
0.13% less ownership
Funds ownership: 6.48% [Q3] → 6.36% (-0.13%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for CDIO.
Financial journalist opinion
Neutral
Business Wire
2 weeks ago
Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics has announced that the Company has partnered with seven new provider organizations.
Neutral
Business Wire
2 months ago
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced their PrecisionCHD and Epi+Gen CHD tests have received final pricing determinations from CMS.
Neutral
Business Wire
3 months ago
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will sponsor and exhibit at the Florida Association of ACOs (FLAACOs) 2024 Annual Fall Conference.
Neutral
Business Wire
4 months ago
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics' PrecisionCHD and Epi+Gen CHD tests have received preliminary pricing determinations from CMS.
Neutral
Business Wire
6 months ago
Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions
CHICAGO--(BUSINESS WIRE)--CDIO.AI emphasizes Cardio Diagnostics' AI-first, scalable solutions for preventing, detecting and managing cardiovascular disease.
Neutral
Business Wire
7 months ago
Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics' clinical blood test, Epi+Gen CHD is now available at FMS' retail clinical location at the Meijer Supercenter in McHenry, IL.
Neutral
Business Wire
7 months ago
Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will sponsor a booth and showcase its groundbreaking cardiovascular solutions at the 2024 Onsite Employee Health Clinics Forum.
Neutral
Business Wire
8 months ago
Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced the successful completion of its System and Organization Controls (SOC) 2 Type I audit.
Neutral
Business Wire
9 months ago
Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services' (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the MolDx program.
Neutral
Business Wire
9 months ago
Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists' Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics' clinical blood tests are now available at FMS' newest clinical location at the Walmart Supercenter in Round Lake Beach, Illinois.
Charts implemented using Lightweight Charts™